S
Sachiko Miyahara
Researcher at Harvard University
Publications - 53
Citations - 4145
Sachiko Miyahara is an academic researcher from Harvard University. The author has contributed to research in topics: Bipolar disorder & Mood. The author has an hindex of 28, co-authored 53 publications receiving 3806 citations. Previous affiliations of Sachiko Miyahara include University of Pittsburgh & Anschutz Medical Campus.
Papers
More filters
Journal ArticleDOI
Long-term implications of early onset in bipolar disorder: Data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Roy H. Perlis,Sachiko Miyahara,Lauren B. Marangell,Stephen R. Wisniewski,Michael J. Ostacher,Melissa P. DelBello,Charles L. Bowden,Gary S. Sachs,Andrew A. Nierenberg +8 more
TL;DR: Very early or early onset of bipolar disorder might herald a more severe disease course in terms of chronicity and comorbidity and whether early intervention might modify this risk merits further investigation.
Journal ArticleDOI
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.
Andrew A. Nierenberg,Mustafa M. Husain,Madhukar H. Trivedi,Maurizio Fava,Diane Warden,S. R. Wisniewski,Sachiko Miyahara,A. J. Rush +7 more
TL;DR: Patients with remission of MDD after treatment with citalopram continue to experience selected residual depressive symptoms, which increase the risk of relapse.
Journal ArticleDOI
Clinical and Diagnostic Implications of Lifetime Attention-Deficit/Hyperactivity Disorder Comorbidity in Adults with Bipolar Disorder: Data from the First 1000 STEP-BD Participants
Andrew A. Nierenberg,Sachiko Miyahara,Thomas J. Spencer,Stephen R. Wisniewski,Michael W. Otto,Naomi M. Simon,Mark H. Pollack,Michael J. Ostacher,Leslie Yan,Rebecca S. Siegel,Gary S. Sachs +10 more
TL;DR: Lifetime ADHD is a frequent comorbid condition in adults with bipolar disorder, associated with a worse course of bipolar disorder and greater burden of other psychiatric comor bid conditions.
Journal ArticleDOI
Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone
Andrew A. Nierenberg,Michael J. Ostacher,Joseph R. Calabrese,Terence A. Ketter,Lauren B. Marangell,David J. Miklowitz,Sachiko Miyahara,Mark S. Bauer,Michael E. Thase,Stephen R. Wisniewski,Gary S. Sachs +10 more
TL;DR: Post hoc secondary analyses suggest that lamotrigine may be superior to inositol and risperidone in improving treatment-resistant bipolar depression.
Journal ArticleDOI
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.
Michael W. Otto,Naomi M. Simon,S. R. Wisniewski,David J. Miklowitz,Julia Kogan,Noreen A. Reilly-Harrington,E. Frank,Andrew A. Nierenberg,Lauren B. Marangell,Kemal Sagduyu,Roger D. Weiss,Sachiko Miyahara,M. E. Thas,Gary S. Sachs,Mark H. Pollack +14 more
TL;DR: Anxiety disorders, including those present during relative euthymia, predicted a poorer bipolar course, and treatment studies targeting anxiety disorders will help to clarify the nature of the impact of anxiety on bipolar course.